He is a member of several national and international scientific associations.

Professor Azorin studied medicine and psychiatry at the University of Marseille Medical School. He was also trained in biological psychiatry at the University of Geneva.

He has been interested in the study of affective symptoms in schizophrenia and involved in the conception and implementation of rating scales devoted to assess anxiety and depression in schizophrenia.

He participated, as a member of review committee, to an International Survey of Depression In Schizophrenia designed to evaluate how depression is currently being treated in clinical practice.

Professor Azorin is an expert for the French National Drugs Agency and contributed to the French Consensus Treatment of Schizophrenia.

He has conducted with H. Akiskal and E. Hantouche national collaborative studies on the clinical characteristics of bipolar mania and depression in France.

Professor Azorin has been principal investigator for many studies of newer antipsychotics and particularly the French/Canadian Clozapine Risperidone Study.

He has published 180 papers on schizophrenia and mood disorders, is the author of one book on vulnerability models in schizophrenia and the co-editor of one textbook on second-generation antipsychotics.